It's Sleep Apnea Awareness Month, and specialist Dr. Evan Temkin stopped by Cheddar News to talk about what the condition is and who is most at risk.
"Sleep apnea is actually a constriction of the airway during sleep, where breathing is interrupted," he said. "Pretty much everybody is at risk."
It affects about 50 percent of the population, he added.
Temkin stressed the importance of getting tested and treated as soon as possible, as prolonged sleep apnea has "cardiac implications."
"When you're not getting enough oxygen to the vital organs, your heart is going to start pumping harder," he said, which taxes the muscle layers in the heart.
The most common treatment for sleep apnea is the use of a CPAP machine, which fits over the nose and mouth to ensure adequate airflow while sleeping, but Temkin noted that it's not the only option.
"One of the big problems with CPAP is compliance," he said. "It's uncomfortable."
One alternative is what's called an "oral appliance," which treats sleep apnea by stabilizing the lower jaw and positioning it a few millimeters forward. This can, in many cases, open up the airway, making it easier for people to breathe freely.
Of course, those experiencing symptoms should see a specialist to see which method is best.
On Monday, football fans were stunned when Buffalo Bills safety Damar Hamlin collapsed and suffered cardiac arrest. Cheddar News explains the condition and the steps to take if you witness an incident.
What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.
Join Cheddar News as we break down the top headlines this morning including updates on the Jan. 6 hears, the PGA suspension of 17 of the world's best golfers, and NASA's plans to study UFOs.
Rick Pauls, President & CEO OF DiaMedica Therapeutics, joins Cheddar Innovates to discuss a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients.
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'
